AMGEN, INC (AMGN)

Currency USD

Company Overview

Amgen Inc. is the leading biotech companies world wide, with a strong presence in the oncology/hematology, cardiovascular disease, neuroscience, inflammation, bone health & nephrology and neuroscience markets. It developed two most successful drugs, Epogen & Neupogen. Amgen successfully launched two next-generation products, Aranesp & Neulasta and also a biosimilar drug, Prolia/Xgeva. The acquisition of Immunex Corp gave Amgen access to the multi-blockbuster drug, Enbrel. Other products are Repatha, Blincyto, Parsabiv, Evenity, Aimovig, Lumakras/Lumykras, Kanjinti, Mvasi & Amgevita biosimilars. Amgen also has a promising pipeline of cancer drugs. It has one of the strongest cash positions in the biotech sector, which could be used to acquire more pipeline assets that could fuel long-term growth. The erythropoiesis-stimulating agents and granulocyte colony-stimulating factor franchise comprise Epogen/Aranesp and Neupogen/Neulasta respectively. Biosimilar drugs are also a key part of Amgen's growth strategy.

Contact Details

Address: ONE AMGEN CENTER DRIVE
City: THOUSAND OAKS
State: CA
Country: USA
Zip Code: 91320
Phone Number: 805-447-1000
Website: -

Financial Highlights

Day Range The price range a stock has traded at during the most recent trading period.: -

-
5 Day Range The price range a stock has traded at during the previous 5 days.: -

-
3 Month Range The price range a stock has traded at during the previous 3 months.: -

-
52 Week Range The price range a stock has traded at during the previous 52 weeks.: -

-
Previous Close The closing price of a stock from the previous day.: -
Open The price of the stock at the start of today’s market opening.: -
Bid The amount of money a trader is willing to pay per share for a given stock.: x
-
Ask The amount of money a seller wants per share of a given stock.: x
-
Volume The number of shares traded in a given period. This number illustrates the active interest in the stock at any time.: -
Avg. Volume The average number of shares traded in a given day.: -
Dividend Yield A company's annual dividend expressed as a percentage of its current stock price.: -
Recent Dividend The value a shareholder receives from a company they are invested in for holding their shares.: -
Beta A measurement of the stock’s volatility in comparison to the market as a whole.: -

Shareholding

Shares Outstanding Number of shares currently held by investors, including restricted shares owned by the company's officers and insiders.: -
Insider Shareholders The percentage of shares owned by any officer or board director of the company, including their related or affiliated individuals, families, entities and trusts.: -
Institutional Shareholders The percentage of shares owned by an institution such as a mutual fund, bank or insurance company.: -

Market Cap The market value of a company’s outstanding shares. It is used as a measurement tool to determine how large a company is.: -
Revenue TTM The amount of money a company has made for the trailing twelve-month period.: -
Net Income TTM A measurement of how much profit they are retaining for the trailing twelve-month period.: -
P/E Ratio The Price to Earnings (P/E) ratio, is calculated by dividing the stock's most recent share price by the sum of the diluted earnings per share.: -
EPS TTM Earnings Per Share (EPS) TTM is a company's profit for the trailing twelve-month period divided by its number of common outstanding shares.: -
1 Year Return A measurement of how much the stock has increased or decreased in the last year.: -